U.S. markets open in 8 hours 2 minutes
  • S&P Futures

    4,617.00
    +27.00 (+0.59%)
     
  • Dow Futures

    35,400.00
    +188.00 (+0.53%)
     
  • Nasdaq Futures

    15,948.75
    +106.00 (+0.67%)
     
  • Russell 2000 Futures

    2,220.90
    +17.30 (+0.79%)
     
  • Crude Oil

    70.54
    +1.05 (+1.51%)
     
  • Gold

    1,782.50
    +3.00 (+0.17%)
     
  • Silver

    22.47
    +0.20 (+0.91%)
     
  • EUR/USD

    1.1298
    +0.0011 (+0.10%)
     
  • 10-Yr Bond

    1.4340
    0.0000 (0.00%)
     
  • Vix

    27.18
    -3.49 (-11.38%)
     
  • GBP/USD

    1.3288
    +0.0027 (+0.21%)
     
  • USD/JPY

    113.7280
    +0.2380 (+0.21%)
     
  • BTC-USD

    51,056.02
    +2,345.68 (+4.82%)
     
  • CMC Crypto 200

    1,318.73
    +58.57 (+4.65%)
     
  • FTSE 100

    7,232.28
    +109.96 (+1.54%)
     
  • Nikkei 225

    28,455.60
    +528.23 (+1.89%)
     

The MEDNAX (NYSE:MD) Share Price Has Gained 69% And Shareholders Are Hoping For More

  • Oops!
    Something went wrong.
    Please try again later.
·2 min read
In this article:
  • Oops!
    Something went wrong.
    Please try again later.

The simplest way to invest in stocks is to buy exchange traded funds. But if you pick the right individual stocks, you could make more than that. For example, the MEDNAX, Inc. (NYSE:MD) share price is up 69% in the last year, clearly besting the market return of around 39% (not including dividends). So that should have shareholders smiling. Unfortunately the longer term returns are not so good, with the stock falling 33% in the last three years.

See our latest analysis for MEDNAX

To paraphrase Benjamin Graham: Over the short term the market is a voting machine, but over the long term it's a weighing machine. One imperfect but simple way to consider how the market perception of a company has shifted is to compare the change in the earnings per share (EPS) with the share price movement.

MEDNAX went from making a loss to reporting a profit, in the last year.

When a company has just transitioned to profitability, earnings per share growth is not always the best way to look at the share price action.

We think that the revenue growth of 3.7% could have some investors interested. Many businesses do go through a phase where they have to forgo some profits to drive business development, and sometimes its for the best.

The graphic below depicts how earnings and revenue have changed over time (unveil the exact values by clicking on the image).

earnings-and-revenue-growth
earnings-and-revenue-growth

MEDNAX is a well known stock, with plenty of analyst coverage, suggesting some visibility into future growth. So it makes a lot of sense to check out what analysts think MEDNAX will earn in the future (free analyst consensus estimates)

A Different Perspective

We're pleased to report that MEDNAX shareholders have received a total shareholder return of 69% over one year. There's no doubt those recent returns are much better than the TSR loss of 10% per year over five years. This makes us a little wary, but the business might have turned around its fortunes. I find it very interesting to look at share price over the long term as a proxy for business performance. But to truly gain insight, we need to consider other information, too. Like risks, for instance. Every company has them, and we've spotted 2 warning signs for MEDNAX (of which 1 doesn't sit too well with us!) you should know about.

But note: MEDNAX may not be the best stock to buy. So take a peek at this free list of interesting companies with past earnings growth (and further growth forecast).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on US exchanges.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.